Ternary Therapeutics (private company)
See something wrong or missing? Let us know
Offices:London
Business model:B2BSAAS
TernaryTx is a British biotech startup founded by Chris Tame and Andrew Potterton and developing an AI-driven platform for designing molecular glue therapeutics - namely an end-to-end platform that combines physics-informed AI with tight experimental feedback loops to rationally design molecular glues.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 4.85M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Ternary Therapeutics
| Name | Criteria | |
|---|---|---|
![]() |
Combinostics
80%
|
|
![]() |
Talkie.ai
80%
|
|
![]() |
DeepSpin
80%
|
|
![]() |
Arkhn
80%
|
|
![]() |
Molecule.one
80%
|
|
![]() |
Cardiomatics
80%
|
|
![]() |
Holly Health
80%
|
|
![]() |
BigOmics Analytics
80%
|
|
![]() |
Juli
80%
|
|
![]() |
clare&me
80%
|
|






Belgium
Netherlands
Austria
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain